American Healthcare REIT Enters Material Definitive Agreement

Ticker: AHR · Form: 8-K · Filed: Nov 18, 2024 · CIK: 1632970

American Healthcare Reit, Inc. 8-K Filing Summary
FieldDetail
CompanyAmerican Healthcare Reit, Inc. (AHR)
Form Type8-K
Filed DateNov 18, 2024
Risk Levelmedium
Pages6
Reading Time7 min
Key Dollar Amounts$0.01, $500 m
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement

Related Tickers: AHIT

TL;DR

AHIT signed a big deal, details TBD.

AI Summary

American Healthcare REIT, Inc. (AHIT) announced on November 18, 2024, the entry into a material definitive agreement. The filing does not disclose specific details of the agreement, the counterparty, or any associated financial figures.

Why It Matters

This filing indicates a significant new contract or transaction for American Healthcare REIT, which could impact its future operations and financial performance.

Risk Assessment

Risk Level: medium — The lack of specific details in the filing creates uncertainty about the nature and impact of the material definitive agreement.

Key Players & Entities

  • American Healthcare REIT, Inc. (company) — Registrant
  • November 18, 2024 (date) — Date of Report

FAQ

What is the nature of the material definitive agreement entered into by American Healthcare REIT, Inc.?

The filing does not specify the nature of the material definitive agreement.

Who is the counterparty to this material definitive agreement?

The filing does not disclose the identity of the counterparty.

Are there any financial terms or dollar amounts associated with this agreement disclosed in the filing?

No, the filing does not provide any financial terms or dollar amounts related to the agreement.

When was this material definitive agreement entered into?

The filing states the date of the earliest event reported is November 18, 2024, which is presumed to be the date of the agreement.

What is the significance of this filing for American Healthcare REIT, Inc.?

This 8-K filing signifies the execution of a material definitive agreement, which is a significant event for the company, though specific details are not yet public.

Filing Stats: 1,788 words · 7 min read · ~6 pages · Grade level 13.4 · Accepted 2024-11-18 09:17:18

Key Financial Figures

  • $0.01 — ange on which registered Common Stock, $0.01 par value per share AHR New York Stock
  • $500 m — an aggregate gross sales price of up to $500 million, or the Shares, through the Agent

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement On November 18, 2024, we and American Healthcare REIT Holdings, LP, or our Operating Partnership, entered into an ATM Equity Offering Sales Agreement, or the Sales Agreement, with BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Citizens JMP Securities, LLC, Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC and Truist Securities, Inc., or each, an Agent, and, collectively, the Agents, and the Forward Purchasers (as defined below), providing for the offer and sale of shares of our common stock, $0.01 par value per share, or Common Stock, having an aggregate gross sales price of up to $500 million, or the Shares, through the Agents, as its sales agents or, if applicable, as forward sellers, or directly to the Agents as principals. The Shares may be offered and sold in amounts and at times to be determined by us from time to time. Actual offers and sales, if any, will depend on a variety of factors to be determined by us and the Agents from time to time, including, among other things, market conditions, the trading price of the Common Stock, capital needs and determinations by us of the appropriate sources of our funding. Sales of the Shares, if any, made pursuant to the Sales Agreement may be sold in negotiated transactions, including block trades, or transactions that are deemed to be "at the market" offerings as defined in Rule 415 under the Securities Act of 1933, as amended, by means of ordinary brokers' transactions at market prices prevailing at the time of sale, including sales made directly on the New York Stock Exchange, sales made to or through a market maker and sales made through other securities exchanges or electronic communications networks. The Agents are not required to sell any specific number or dollar amount of Shares but have agreed to use th

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 ATM Equity Offering Sales Agreement, dated as of November 18, 2024 5.1 Opinion of Venable LLP 23.1 Consent of Venable LLP (included in Exhibit 5.1) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. American Healthcare REIT, Inc. November 18, 2024 By: /s/ Danny Prosky Name: Danny Prosky Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.